Navigation Links
Choose New Jersey and Partners to Promote New Jersey As Global Life Science Hub at World's Largest Biotechnology Event
Date:4/22/2013

PRINCETON, N.J., April 22, 2013 /PRNewswire/ -- To showcase New Jersey as one of the world's premiere locations for life science companies and medical research, Choose New Jersey, Inc. is collaborating with Lt. Governor Kim Guadagno , the Business Action Center (BAC), BioNJ, the HealthCare Institute of New Jersey (HINJ) and other partners at the BIO International Convention in Chicago on April 22-25, 2013.

(Logo:  http://photos.prnewswire.com/prnh/20120618/NY26273LOGO )

This is the third year in a row that Choose New Jersey has led a delegation to BIO International, which is considered the largest biotechnology event in the world. Last year, the conference drew more than 16,500 industry leaders from 49 states and 65 countries, including large delegations from Canada, UK, Germany, France, Japan, South Korea, Spain, Australia, China and Brazil.

"New Jersey offers unrivaled opportunities for pharmaceutical, biotechnology and medical device businesses," said Lt. Governor Guadagno. "BIO International is the perfect forum for sharing our state's competitive advantages with this highly targeted international audience. Simply put, our goal is to attract the businesses that will help sustain and grow the $58 billion economic output that the biopharmaceutical sector already contributes to the Garden State."

Representatives from the New Jersey delegation - the largest from the Garden State to attend this event in recent years - will meet with life science companies that have been identified as prospects for expanding or relocating to New Jersey, as well as with business and trade media covering the event. Choose New Jersey has also placed targeted advertising on mobile billboards and publications aimed at conference attendees.

"New Jersey is home to 14 out of the 20 largest biopharmaceutical companies, more than 3,100 biotechnology and pharmaceutical companies and a thriving medical technology industry," said Tracye McDaniel , President and CEO of Choose New Jersey. "With more scientists and engineers per square mile than anywhere else on the planet, three medical schools among our 63 colleges and universities and 13 teaching hospitals, we offer biopharmaceutical companies a 'brain belt' second to none."  

Choose New Jersey is collaborating with BioNJ, HINJ and five New Jersey universities on the New Jersey pavilion at the conference, which will be emblazoned with the slogan "Big Ideas Happen Here." Participating universities include New Jersey Institute of Technology (NJIT), Princeton University, Rutgers University, Stevens Institute of Technology, and the University of Medicine and Dentistry of New Jersey (UMDNJ). Additional companies representing New Jersey include Avison Young , Celgene Corporation, Genova Burns Giantomasi & Webster and Jones Lang LaSalle Americas.

Lt. Governor Guadagno and Choose New Jersey will also host prospect companies for a special dinner event on April 23. Sponsored by HINJ, the evening will provide networking opportunities for some of the world's top life science executives and will feature a presentation by Paul Hoffman , CEO of the Liberty Science Center.

About Choose New Jersey, Inc.
Choose New Jersey is one of four elements of the Partnership for Action (PFA) economic development organization led by Lt. Governor Kim Guadagno . The PFA includes the Business Action Center, which provides the business community with a single point of contact, and applies a proactive, customer-service approach to businesses' interactions with State government; the Secretary of Higher Education, which coordinates, plans, develops policies, and advocates for the state's higher education system; the New Jersey Economic Development Authority, serving as the State's financing arm; and Choose New Jersey, a privately funded marketing, business attraction and lead generation organization that markets the state as an ideal location. For more information, visit www.chooseNJ.com.

Contact: Melissa Hensley , 609-297-2192
mhensley@choosenj.com


'/>"/>
SOURCE Choose New Jersey, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Choose New Jersey, Inc. to Tout New Jerseys Life Sciences Hub At Worlds Largest Biotechnology Event
2. New England Cord Blood Bank chooses Sepax 2 from Biosafe as their Cord Blood Processing Platform
3. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
4. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
5. Promoting the States Quality of Life, New Jersey Symphony Orchestra to Perform at BIO International Convention
6. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
7. Reproductive Medicine Associates of New Jersey and Auxogyn Launch Fertility Study To Advance Goals of One Embryo, One Healthy Baby
8. Biggest Names in Pharmaceutical, Healthcare Industry to Gather for Groundbreaking Event in Parsippany, New Jersey on September 11-12, 2012
9. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
10. New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
11. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 ... (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... an ihre Pressemitteilung vom 13. August 2015 die ... ihre Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 ... Dollar zu bringen. Davon wurden 157.900.000 Einheiten mit ...
(Date:4/27/2016)... Virgin Islands (PRWEB) , ... April 27, 2016 ... ... Company Ltd. (d/b/a Biohaven) is pleased to announce the appointment of John Tilton as ... was an Executive Director and one of the founding commercial leaders responsible for ...
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., ... Advisory Board. Dr. Lamka will assist PathSensors in expanding the use of the ... deploys the CANARY® test platform for the detection of harmful pathogens, including a ...
(Date:4/27/2016)... ... 2016 , ... Global Stem Cells Group CEO Benito Novas announced ... of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. ... for hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM ...
Breaking Biology Technology:
(Date:3/14/2016)... March 14, 2016 NXTD ) ("NXT-ID" ... commerce market, announces the airing of a new series of ... week of March 21 st .  The commercials will air ... popular Squawk on the Street show. --> NXTD ... growing mobile commerce market, announces the airing of a new ...
(Date:3/11/2016)... --> --> ... Recognition Market by Technology (Pattern Recognition), by Component (Hardware, ... Type (On-Premises and Cloud), by Industry Vertical and by ... the global market is expected to grow from USD ... 2020, at a CAGR of 19.1%. , ...
(Date:3/9/2016)... 9, 2016 This BCC Research report provides ... the RNA Sequencing (RNA Seq) market for the years ... tools and reagents, data analysis, and services. ... the RNA-Sequencing market such as RNA-Sequencing tools and reagents, ... factors affecting each segment and forecast their market growth, ...
Breaking Biology News(10 mins):